Effectiveness, Efficacy, and Safety of XGEVA (denosumab) in Chinese Patients With Giant Cell Tumor of Bone (GCTB): A Systematic Literature Review (20220044)

28/09/2022
05/12/2023
EU PAS number:
EUPAS49061
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Protocol-Published Original denosumab 20220044

English (489.33 KB - PDF) View document
Study results
Study results

20220044_ORSR Abstract_28MAR2023_Redacted

English (104.26 KB - PDF) View document
Study report
Other information